Compounds > propentofylline
Page last updated: 2024-11-03

propentofylline and Cerebral Infarction, Middle Cerebral Artery

propentofylline has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies

Research Excerpts

ExcerptRelevanceReference
"BACKGROUND AND PUROSEe: in this study we tested the potentially neuroprotective properties of propentofylline in a model of focal ischemia with long-term, repeated treatment."7.70Effect of propentofylline (HWA 285) on focal ischemia in rats: effect of treatment and posttreatment duration on infarct size. ( Haag, P; Hacke, W; Schäbitz, W; Schneider, T, 2000)
"BACKGROUND AND PUROSEe: in this study we tested the potentially neuroprotective properties of propentofylline in a model of focal ischemia with long-term, repeated treatment."3.70Effect of propentofylline (HWA 285) on focal ischemia in rats: effect of treatment and posttreatment duration on infarct size. ( Haag, P; Hacke, W; Schäbitz, W; Schneider, T, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haag, P1
Schneider, T1
Schäbitz, W1
Hacke, W1

Other Studies

1 other study available for propentofylline and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Effect of propentofylline (HWA 285) on focal ischemia in rats: effect of treatment and posttreatment duration on infarct size.
    Journal of the neurological sciences, 2000, Apr-01, Volume: 175, Issue:1

    Topics: Animals; Cerebral Cortex; Infarction, Middle Cerebral Artery; Ischemia; Male; Neuroprotective Agents

2000